Skip to main content
. 2021 Apr 7;17:285–292. doi: 10.2147/TCRM.S263835

Table 2.

Predictors of Response and Non-Response to Budesonide MMX Therapy

Predictors of Response Predictors of Non-Response
Left-sided colitis[6] Extensive colitis[6,7]
Rectal bleeding[13] Concomitant therapy with biologics and immunosoppressants[14]
Physicians’ Global Assessment[13] Degree of disease activity[14]
Compliance to treatment[13] Male sex[15]
Age < 29[15]